3Egawa S, Takeda K, Fukuyama S, et al. Clinicopathological as- pects of small pancreatic cancer. Pancreas,2004,28(3 ) :235-240.
4Kayahara M, Funaki K, Tajima H, et al. Surgical implication of micrometastasis for pancreatic cancer. Pancreas, 2010,39 ( 6 ) : 884-888.
5Kurahara H, Takao S, Maemura K, et al. Impact of lymph node micrometastasis in patients with pancreatic head cancer. World J Surg,2007,31 (3) :483-492.
6Balie M, Williams A, Dandachi N, et al. Micrometastasis: detec- tion methods and clinical importance. Cancer Biomark,2011,9( 1- 6) :397-419.
7Lee SE, Jang JY, Kim MA, et al. Clinical implications of inmm- nohistochemically demonstrated lymph node micrometastasis in re- sectable pancreatic cancer. J Korean Med Sci,2011,26 (7) : 881 - 885.
8Kat'uchov:i J, Bober J, Kat'uch V, et al. Significance of lymph node micrometastasis in pancreatic cancer patients. Eur Surg Res, 2012,48(1) :10-15.
9Derneure M J, Doffek KM, Komorowski RA, et al. Adenocat:inn- ma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay. Cancer, 1998,83(7) :1328-1334.
10Tanaka S, Pero SC, Taguchi K, et al. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis. J Natl Cancer Inst,2006,98 (7) :491-498.
